-Carlo M Croce Researcher Activity Profile

Research Author Detailed Information 

Carlo M Croce Publication Rate By Year

Carlo M Croce has published 1 paper(s) in 1983, 1 paper(s) in 1994, 2 paper(s) in 1998, 1 paper(s) in 1999, 1 paper(s) in 2000, 4 paper(s) in 2006, 34 paper(s) in 2007, 16 paper(s) in 2008, for a total of 60 research publications in total.

Carlo M Cm Croce Author Information

LAST NAME: croce

FIRST NAME: Carlo M

INITIALS: cm

AFFILIATION:

Papers

Carlo M Croce's Publication Record

1. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. Year Published: 2007
Division of Surgical Oncology, James Cancer Hospital and Solove Research Institute, Ohio State University, Columbus, USA. mark.bloomston@osumc.edu
2. MicroRNA-133 controls cardiac hypertrophy. Year Published: 2007
3. Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35. Year Published: 2006
Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, USA. pichiorri.1@osu.edu
4. Fhit modulates the DNA damage checkpoint response. Year Published: 2006
Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
5. Cellular localization of the bcl-2 protein and response to glucocorticoid stress. Year Published: 2006
Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
6. A microRNA signature of hypoxia. Year Published: 2007
Molecular Oncology Research Institute, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA.
7. Targeted deletion of Wwox reveals a tumor suppressor function. Year Published: 2007
Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, 410 West 12th Avenue, Columbus, OH 43210, USA. rami.aqeilan@osumc.edu
8. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Year Published: 2007
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD 21204, USA. rgeorgan@jhmi.edu
9. MicroRNA expression profiles for the NCI-60 cancer cell panel. Year Published: 2007
Program of Pharmacogenomics, Department of Pharmacology and the Comprehensive Cancer Center, College of Medicine, The Ohio State University, 5072 Graves Hall, 333 West 10th Avenue, Columbus, OH 43210, USA. blower.7@osu.edu
10. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Year Published: 2007
Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.
11. Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo. Year Published: 2007
Division of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus, Ohio 43210, USA. rami.aqeilan@osumc.edu
12. Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing. Year Published: 2007
*Department of Molecular Virology, Immunology, and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210.
13. Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis. Year Published: 2007
*Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom.
14. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Year Published: 2007
15. Investigation of MicroRNA Alterations in Leukemias and Lymphomas. Year Published: 2007
Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
16. ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias. Year Published: 2007
Department of Molecular Virology, Immunology, and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.
17. Micro-RNA profiling in kidney and bladder cancers. Year Published: 2007
Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
18. MicroRNA signatures in human ovarian cancer. Year Published: 2007
Molecular Biology Unit, Department of Experimental Oncology, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milano, Italy.
19. Association of Wwox with ErbB4 in breast cancer. Year Published: 2007
Department of Molecular Virology, Immunology and Medical Genetics, Human Cancer Genetics Program, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210, USA. rami.aqeilan@osumc.edu
20. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. Year Published: 2007
Ohio State University, Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Columbus, OH 43210, USA.
21. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Year Published: 2007
Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, and College of Pharmacy, Ohio State University, Columbus, OH 43210, USA.
22. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Year Published: 2007
23. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Year Published: 2007
24. Interferon modulation of cellular microRNAs as an antiviral mechanism. Year Published: 2007
Department of Molecular Biology, University of California San Diego, La Jolla, California 92093, USA.
25. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Year Published: 2007
Department of Experimental and Diagnostic Medicine and Interdepartment Center for Cancer Research, University of Ferrara, Ferrara, Italy. lng@unife.it
26. Fez1/Lzts1 a new mitotic regulator implicated in cancer development. Year Published: 2007
Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, OH, USA. carlo.croce@osumc.edu.
27. Influence of a nonfragile FHIT transgene on murine tumor susceptibility. Year Published: 2007
Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
28. MicroRNAs in carcinogenesis. Year Published: 2007
Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA. john.hagan@osumc.edu
29. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia. Year Published: 2007
Department of Experimental Therapeutics, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
30. Micro-RNA profiling in kidney and bladder cancers. Year Published: 2007
Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
31. Expression profiling of microRNA using oligo DNA arrays. Year Published: 2007
Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Wiseman Hall Room 385, 400 12th Avenue, Columbus, OH 43210, United States.
32. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Year Published: 2007
Department of Experimental and Diagnostic Medicine and Interdepartment Center for Cancer Research, University of Ferrara, Ferrara, Italy. lng@unife.it
33. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Year Published: 2007
34. TCL1 promotes blastomere proliferation through nuclear transfer, but not direct phosphorylation, of AKT/PKB in early mouse embryos. Year Published: 2008
[1] 1Istituto Pasteur - Fondazione Cenci Bolognetti, Sapienza University, Rome 00185, Italy [2] 2Section of Neuroscience, Department of Psychology, Sapienza University, Rome 00185, Italy.
35. Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing. Year Published: 2007
*Department of Molecular Virology, Immunology, and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210.
36. Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis. Year Published: 2007
*Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom.
37. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Year Published: 2007
38. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Year Published: 2008
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
39. MicroRNAs modulate the chemosensitivity of tumor cells. Year Published: 2008
Program of Pharmacogenomics, Department of Pharmacology, Ohio State University, 333 West Tenth Street, Columbus, OH 43210. blower.7@osu.edu.
40. Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. Year Published: 1994
Jefferson Cancer Institute, Jefferson Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
41. Oncogenes and cancer. Year Published: 2008
Department of Molecular Virology, Immunology, and Medical Genetics and the Human Cancer Genetics Program, Ohio State University Medical Center, Columbus, OH 43210, USA. carlo.croce@osumc.edu
42. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Year Published: 2008
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
43. Oncogenes and cancer. Year Published: 2008
Department of Molecular Virology, Immunology, and Medical Genetics and the Human Cancer Genetics Program, Ohio State University Medical Center, Columbus, OH 43210, USA. carlo.croce@osumc.edu
44. Oncogenes and cancer. Year Published: 2008
Department of Molecular Virology, Immunology, and Medical Genetics and the Human Cancer Genetics Program, Ohio State University Medical Center, Columbus, OH 43210, USA. carlo.croce@osumc.edu
45. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Year Published: 2006
Comprehensive Cancer Center, Human Cancer Genetics Program and Department of Molecular Virology, Immunology, and Medical Genetics, OSU School of Medicine, Ohio State University, Columbus, Ohio 43210, USA. Pekarsky.Yuri@osumc.edu
46. Chromosomal proteins of mouse teratocarcinoma cells. Year Published: 1983
47. The role of deletions at the FRA3B/FHIT locus in carcinogenesis. Year Published: 1999
Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
48. Expression profiling of microRNA using oligo DNA arrays. Year Published: 2007
Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Wiseman Hall Room 385, 400 12th Avenue, Columbus, OH 43210, United States.
49. Compatible solutes from hyperthermophiles improve the quality of DNA microarrays. Year Published: 2008
Dipartimento di Morfologia ed Embriologia and DAMA, Data Mining for Analysis of DNA Microarrays, Telethon Facility, Università degli Studi di Ferrara, Ferrara, Italy. nicoletta.mascellani@gmail.com
50. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Year Published: 2008
Departments of Medicine and Molecular Virology and Human Genetics, Comprehensive Cancer Center, and College of Pharmacology, Ohio State University, Columbus, OH 43221, USA.
51. Crystal structure of the worm NitFhit Rosetta Stone protein reveals a Nit tetramer binding two Fhit dimers. Year Published: 2000
Structural Biology and Bioinformatics Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
52. Purification and crystallization of complexes modeling the active state of the fragile histidine triad protein. Year Published: 1998
Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA.
53. Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans. Year Published: 1998
Kimmel Cancer Institute, Jefferson Medical College, Philadelphia, PA 19107, USA.
54. Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis. Year Published: 2008
Department of Urology, Anatomy and Cell Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA. r_baffa@mail.jci.tju.edu
55. MiR-15a and miR-16-1 cluster functions in human leukemia. Year Published: 2008
Human Cancer Genetics Program and Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University, Columbus, OH 43210.
56. TCL1 promotes blastomere proliferation through nuclear transfer, but not direct phosphorylation, of AKT/PKB in early mouse embryos. Year Published: 2008
57. MicroRNAs modulate the chemosensitivity of tumor cells. Year Published: 2008
Program of Pharmacogenomics, Department of Pharmacology, Ohio State University, 333 West Tenth Street, Columbus, OH 43210, USA. blower.7@osu.edu
58. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Year Published: 2008
Department of Molecular Virology, Immunology and Medical Genetics, Human Cancer Genetics Program, Ohio State University, 460 West 12th Avenue, Columbus, OH 43210, USA.
59. MiR-15a and miR-16-1 cluster functions in human leukemia. Year Published: 2008
Human Cancer Genetics Program and Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University, Columbus, OH 43210, USA. gcalin@mdanderson.org
60. MicroRNA expression profiling using microarrays. Year Published: 2008
Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.